APA (7th ed.) Citation

M, B., G, I., V, N., C, M., P, M., L, M., . . . A, M. G. (2026). Real-world resource utilization, toxicity management, and efficacy outcomes of CD20 × CD3 bispecific antibodies in B-cell lymphoma: A study from the GELTAMO network. HemaSphere, 10(6), e70398. https://doi.org/10.1002/hem3.70398

Chicago Style (17th ed.) Citation

M, Bastos-Oreiro, et al. "Real-world Resource Utilization, Toxicity Management, and Efficacy Outcomes of CD20 × CD3 Bispecific Antibodies in B-cell Lymphoma: A Study from the GELTAMO Network." HemaSphere 10, no. 6 (2026): e70398. https://doi.org/10.1002/hem3.70398.

MLA (9th ed.) Citation

M, Bastos-Oreiro, et al. "Real-world Resource Utilization, Toxicity Management, and Efficacy Outcomes of CD20 × CD3 Bispecific Antibodies in B-cell Lymphoma: A Study from the GELTAMO Network." HemaSphere, vol. 10, no. 6, 2026, p. e70398, https://doi.org/10.1002/hem3.70398.